Evaluation of FOXO1 Target Engagement Using a Single-Cell Microfluidic Platform.

Osman, Suhuur; Bendtsen, Claus; Peel, Samantha; Yrlid, Linda; Muthas, Daniel; Simpson, John; Willison, Keith R; Klug, David R

Osman, Suhuur; Bendtsen, Claus; Peel, Samantha; Yrlid, Linda; Muthas, Daniel; Simpson, John; Willison, Keith R; Klug, David R.

Afiliación

Osman S; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, 80 Wood Lane, London, W12 0BZ, United Kingdom.
Bendtsen C; Discovery Sciences, R&D, AstraZeneca, 310 Milton Road, Cambridge, CB4 0WG, United Kingdom.
Peel S; Discovery Sciences, R&D, AstraZeneca, 310 Milton Road, Cambridge, CB4 0WG, United Kingdom.
Yrlid L; Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 Gothenburg, Sweden.
Muthas D; Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43150 Gothenburg, Sweden.
Simpson J; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, 80 Wood Lane, London, W12 0BZ, United Kingdom.
Willison KR; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, 80 Wood Lane, London, W12 0BZ, United Kingdom.
Klug DR; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, 80 Wood Lane, London, W12 0BZ, United Kingdom.

Anal Chem ; 93(44): 14659-14666, 2021 11 09.

Article en En | MEDLINE | ID: mdl-34694778

Asunto(s)

Descubrimiento de Drogas; Microfluídica; Proteínas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Microfluídica / Descubrimiento de Drogas Idioma: En Revista: Anal Chem Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google